CoChat

Analytical Validation of Multiplex Biomarker Assay to Stratify Colorectal Cancer into Molecular Subtypes

Open access
Ragulan, Chanthirika, Eason, Katherine, Fontana, Elisa, Nyamundanda, Gift, Tarazona, Noelia, Patil, Yatish, Poudel, Pawan, Lawlor, Rita T., Del Rio, Maguy, Koo, Si-Lin, Tan, Wah-Siew, Sclafani, Francesco, Begum, Ruwaida, Teixeira Mendes, Larissa S., Martineau, Pierre, Scarpa, Aldo, Cervantes, Andrés, Tan, Iain Beehuat, Cunningham, David, Sadanandam, Anguraj · 2019 · Scientific Reports
Cited by 48

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Abstract

Previously, we classified colorectal cancers (CRCs) into five CRCAssigner (CRCA) subtypes with different prognoses and potential treatment responses, later consolidated into four consensus molecular subtypes (CMS). Here we demonstrate the analytical development and validation of a custom NanoString nCounter platform-based biomarker assay (NanoCRCA) to stratify CRCs into subtypes. To reduce costs, we switched from the standard nCounter protocol to a custom modified protocol. The assay included a reduced 38-gene panel that was selected using an in-house machine-learning pipeline. We applied NanoCRCA to 413 samples from 355 CRC patients. From the fresh frozen samples (n = 237), a subset had matched microarray/RNAseq profiles (n = 47) or formalin-fixed paraffin-embedded (FFPE) samples (n = 58). We also analyzed a further 118 FFPE samples. We compared the assay results with the CMS classifier, different platforms (microarrays/RNAseq) and gene-set classifiers (38 and the original 786 genes). The standard and modified protocols showed high correlation (> 0.88) for gene expression. Technical replicates were highly correlated (> 0.96). NanoCRCA classified fresh frozen and FFPE samples into all five CRCA subtypes with consistent classification of selected matched fresh frozen/FFPE samples. We demonstrate high and significant subtype concordance across protocols (100%), gene sets (95%), platforms (87%) and with CMS subtypes (75%) when evaluated across multiple datasets. Overall, our NanoCRCA assay with further validation may facilitate prospective validation of CRC subtypes in clinical trials and beyond.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41598-019-43492-0

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Cited by

See all 48

Metadata

Authors
Ragulan, C., Eason, K., Fontana, E., Nyamundanda, G., Tarazona, N., Patil, Y., Poudel, P., Lawlor, R. T., Del Rio, M., Koo, S.-L., Tan, W.-S., Sclafani, F., Begum, R., Teixeira Mendes, L. S., Martineau, P., Scarpa, A., Cervantes, A., Tan, I. B., Cunningham, D., & Sadanandam, A.
Venue
Scientific Reports
Published
2019-05-21
Volume
9
Issue
1
Pages
7665-7665
ISSN
2045-2322 (ISSN-L)
OpenAlex
W2945558375
Cited by
48
References
8
FWCI
2.29
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Analytical Validation of Multiplex Biomarker Assay to Stratify Colorectal Cancer into Molecular Subtypes. https://app.cochat.ai/papers/10.1038/s41598-019-43492-0
The paper
Ragulan, C., Eason, K., Fontana, E., Nyamundanda, G., Tarazona, N., Patil, Y., Poudel, P., Lawlor, R. T., Del Rio, M., Koo, S.-L., Tan, W.-S., Sclafani, F., Begum, R., Teixeira Mendes, L. S., Martineau, P., Scarpa, A., Cervantes, A., Tan, I. B., Cunningham, D., & Sadanandam, A. (2019). Analytical Validation of Multiplex Biomarker Assay to Stratify Colorectal Cancer into Molecular Subtypes. Scientific Reports. https://doi.org/10.1038/s41598-019-43492-0

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.